Nkarta NKTX
NASDAQ NKTX
$1.48 +0.13 (+9.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Nkarta (NKTX) Asset Writedowns and Impairment (2023 - 2026)

Updated

Nkarta (NKTX) posted Asset Writedowns and Impairment of $5.67 million for Q2 2026.

Analysis

Nkarta (NKTX) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Asset Writedowns and Impairment at Nkarta was $6.46 million; for FY2025, it was $791,000.

  • In prior years, Nkarta's Asset Writedowns and Impairment was $4.1 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Nkarta 96.80 Mn -1.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00 Mn
Sep 30, 2025 791,000.00
Jun 30, 2023 4.10 Mn
API Access

Nkarta Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=NKTX&period=max&api_key=YOUR_API_KEY